Back to search results

Cryotherapy for Localized Prostate Cancer

This study is creating a database to track the experiences of men who receive cryotherapy for prostate cancer that is only in the prostate (clinically localized prostate cancer). Researchers want to understand the long-term results of this treatment. You may be able to join if you are a man between 40 and 85 years old with prostate cancer that is confined to the prostate, as shown by MRI scans and biopsies. The study will look at how often treatment complications happen and how long men live without their prostate-specific antigen (PSA) levels rising, which can be a sign of cancer returning. The study aims to include 1000 participants. The current recruitment status is unclear.

Study design
This is an observational study collecting information from 1000 participants. It is not testing a new intervention but rather observing outcomes of an existing treatment.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for treatment complications and PSA-Progression Free Survival for up to 15 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07184957

Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

Recruiting
Not specifiedAges 40–85Observational
NYU Langone Health
~1,000 participants
Updated 2026-08-07 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Treatment Complications
Measured over Up to Year 15
+1 more outcome measured

Conditions

Prostate Cancer

Explore related trials

Prostate Carcinoma

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • James Wysock, MD · PRINCIPAL_INVESTIGATOR · NYU Langone Health

Who to contact

Majlinda Tafa
[email protected]
(646) 825-6338
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy
Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection.

Exclusion

Men that are not diagnosed with prostate cancer.
Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.

What this trial measures

  • Treatment ComplicationsUp to Year 15
  • PSA-Progression Free SurvivalUp to Year 15

    Length of time following cryotherapy for ablation treatment of prostate cancer that a patient lives without their prostate-specific antigen (PSA) levels rising significantly enough to indicate disease recurrence, or without dying from any cause.